Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:SMA

Symmetry Medical (SMA) Stock Price, News & Analysis

Symmetry Medical logo

About Symmetry Medical Stock (NYSE:SMA)

Advanced Chart

Key Stats

Today's Range
$35.50
$37.74
50-Day Range
$13,350.00
$16,000.00
52-Week Range
N/A
Volume
558,936 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.30
Consensus Rating
Buy

Company Overview

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Receive SMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Symmetry Medical and its competitors with MarketBeat's FREE daily newsletter.

SMA Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

SMA Stock Analysis - Frequently Asked Questions

Symmetry Medical Inc (NYSE:SMA) released its quarterly earnings data on Wednesday, May, 7th. The healthcare company reported $0.41 earnings per share for the quarter, meeting analysts' consensus estimates of $0.41. The healthcare company earned $65.45 million during the quarter, compared to analysts' expectations of $63.63 million.
Read the conference call transcript
.

Symmetry Medical (SMA) raised $810 million in an initial public offering on Wednesday, April 2nd 2025. The company issued 27,000,000 shares at a price of $30.00 per share.

Symmetry Medical's quiet period expires on Monday, May 12th. Symmetry Medical had issued 27,000,000 shares in its IPO on April 2nd. The total size of the offering was $810,000,000 based on an initial share price of $30.00. During Symmetry Medical's quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Based on aggregate information from My MarketBeat watchlists, some other companies that Symmetry Medical investors own include Consort Medical plc (CSRT.L) (CSRT), Achillion Pharmaceuticals (ACHN), Boeing (BA), Cencora (COR), Alphabet (GOOG), Illumina (ILMN) and Newcrest Mining (NCM).

Company Calendar

Last Earnings
5/07/2025
Today
5/11/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:SMA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$38.30
High Stock Price Target
$40.00
Low Stock Price Target
$36.00
Potential Upside/Downside
+4.8%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
12 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:SMA) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners